Whalesbook
Sudeep Pharma's IPO is drawing massive investor interest, with subscriptions surging past 8 times the offer size on its final bidding day, November 25. Non-Institutional Investors booked over 22 times their quota, and retail investors subscribed nearly 7 times. Despite this strong demand, the grey market premium (GMP) has dropped to around 14%, sparking investor caution. The Rs 895 crore IPO aims to fund machinery procurement and general corporate needs.